What is the flowchart approach for managing dengue fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dengue Fever Management Flowchart

Initial Assessment and Diagnosis

Begin with fever plus two or more of: headache, retro-orbital pain, myalgia, arthralgia, or rash occurring 4-8 days after potential mosquito exposure. 1

Diagnostic Testing Algorithm

  • Days 1-7 of symptoms: Order dengue PCR/NAAT on serum 1, 2
  • After day 5-7 of symptoms: Order IgM capture ELISA if PCR unavailable or negative 1, 2
  • NS1 antigen: Useful days 1-10 after symptom onset 3
  • Document vaccination history for yellow fever, Japanese encephalitis, and tick-borne encephalitis to avoid cross-reactivity 1
  • Pregnant women: Test by NAAT for both dengue and Zika virus regardless of outbreak patterns 1

Baseline Laboratory Monitoring

  • Complete blood count with platelet count and hematocrit 1, 2
  • Repeat CBC daily to track trends 1, 2

Risk Stratification: Three Categories

Group A: Dengue Without Warning Signs

Clinical features: Fever, headache, retro-orbital pain, myalgia, arthralgia, rash, no warning signs 3

Management:

  • Outpatient management appropriate 1
  • Acetaminophen at standard doses for fever and pain 1, 2
  • Never use aspirin or NSAIDs due to bleeding risk and platelet dysfunction 1, 2
  • Oral hydration with oral rehydration solutions targeting >2500ml daily 1, 2
  • Daily CBC monitoring 1, 2
  • Patient education on warning signs 1

Group B: Dengue With Warning Signs (Requires Hospitalization)

Warning signs include: 1, 3

  • Persistent vomiting
  • Abdominal pain or tenderness
  • Clinical fluid accumulation (pleural effusion, ascites)
  • Mucosal bleeding
  • Lethargy or restlessness
  • Hepatomegaly >2 cm
  • Rising hematocrit with concurrent rapid platelet decline

These typically appear days 3-7 during defervescence 3

Management:

  • Immediate hospitalization for close monitoring 3
  • Intravenous isotonic crystalloid fluids 1
  • Continuous monitoring: vital signs, urine output (target >0.5 mL/kg/hour), hematocrit every 4-6 hours 1, 2
  • Daily CBC 1, 2
  • Acetaminophen only for fever/pain 1, 2
  • Monitor for progression to Group C 1

Group C: Severe Dengue (Dengue Shock Syndrome or Severe Bleeding)

Dengue Shock Syndrome criteria: 3

  • Systolic BP <90 mmHg for >30 minutes OR
  • Pulse pressure <20 mmHg (more sensitive early indicator) OR
  • Signs of end-organ hypoperfusion: cold/clammy extremities, capillary refill ≥3 seconds, elevated lactate >2 mmol/L

Immediate Management:

  • Administer 20 mL/kg isotonic crystalloid bolus over 5-10 minutes 1, 2
  • Reassess immediately after bolus completion 1, 2
  • If pulse pressure remains <10 mmHg or persistent shock, consider colloid solutions 1, 2
  • Repeat 20 mL/kg boluses as needed based on reassessment 1
  • If persistent tissue hypoperfusion despite adequate fluid resuscitation, initiate vasopressors (dopamine or epinephrine) 1, 2
  • Continuous cardiac telemetry and pulse oximetry 1, 2
  • Blood transfusion for significant bleeding 1

Critical Pitfall: Narrow pulse pressure <20 mmHg is an earlier indicator than absolute hypotension—monitor closely 3

Critical Pitfall: Avoid over-resuscitation as excessive fluids worsen outcomes due to underlying plasma leakage pathophysiology 3


Monitoring During Hospitalization

Daily Requirements

  • Complete blood count to track platelet counts and hematocrit 1, 2
  • Vital signs with attention to pulse pressure 3
  • Urine output monitoring (target >0.5 mL/kg/hour in adults) 1, 2
  • Fluid balance charting 1

If Fever Persists Beyond 5 Days

  • Obtain blood and urine cultures 1
  • Chest radiograph 1
  • Broaden management to cover potential secondary bacterial infections if hemodynamically unstable 1
  • Do not change antibiotics based solely on persistent fever without clinical deterioration or new findings 1

Discharge Criteria (All Must Be Met)

Patients can be safely discharged when: 1, 2

  • Afebrile for ≥48 hours without antipyretics
  • Resolution or significant improvement of symptoms
  • Stable hemodynamic parameters for ≥24 hours without support (normal heart rate, stable BP, normal capillary refill)
  • Adequate oral intake maintained
  • Adequate urine output (>0.5 mL/kg/hour in adults)
  • Laboratory parameters returning to normal ranges

Post-Discharge Instructions

  • Monitor and record temperature twice daily 1
  • Return immediately if: Temperature ≥38°C on two consecutive readings OR any warning signs develop 1

Special Population Considerations

Pregnant Women

  • Test by NAAT for both dengue and Zika virus 1
  • Acetaminophen is the safest analgesic option 1, 2

Children

  • Acetaminophen dosing must be carefully calculated based on weight 1, 2
  • Same risk stratification and management principles apply 1

Key Pitfalls to Avoid

  • Never use aspirin or NSAIDs when dengue cannot be excluded 1, 2
  • Do not delay fluid resuscitation in patients showing signs of shock 1
  • Monitor pulse pressure closely—it is more sensitive than absolute hypotension for detecting early shock 3
  • Avoid over-resuscitation in dengue shock syndrome 3
  • Do not discharge patients before meeting all discharge criteria 1, 2

References

Guideline

Dengue Fever Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Dengue and Chikungunya

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Danger Signs of Dengue

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.